Following the completion of our formal separation from GSK global in July 2022, Haleon launched as an independent company 100% focused on consumer health. Haleon engages in our business driven by our purpose to Deliver better everyday health with humanity.

With a focus on innovation, deep human understanding and trusted science, we will contribute to consumer health with our extensive portfolio of brands in oral healthcare and OTC drugs in Japan, Its long-standing brands – such as Shumitect (Sensodyne), Kamutect (parodontax), Polident/Poligrip, Voltaren and Contac.